<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-09T09:26:30Z</responseDate>
  <request identifier="oai:figshare.com:article/34053837" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34053837</identifier>
        <datestamp>2026-10-02T04:40:10Z</datestamp>
        <setSpec>category_140</setSpec>
        <setSpec>portal_316</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_10_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Data Sheet 1_Incremental value of dedicated [201Tl] cadmium-zinc-telluride thallium SPECT over rest/stress [99mTc] technetium sestamibi SPECT MPI: a comparative analysis of fixed perfusion defects.docx</dc:title>
          <dc:creator>Phattaraphorn Teungsang (25161840)</dc:creator>
          <dc:creator>Methawee Laohamethanee (25161843)</dc:creator>
          <dc:creator>Napat Kitkhuandee (25161846)</dc:creator>
          <dc:creator>Thanapol Kliteneam (25161849)</dc:creator>
          <dc:creator>Daris Theerakulpisut (5843717)</dc:creator>
          <dc:subject>Cardiology</dc:subject>
          <dc:subject>cardiovascular imaging</dc:subject>
          <dc:subject>myocardial perfusion abnormality</dc:subject>
          <dc:subject>perfusion defect quantification</dc:subject>
          <dc:subject>radionuclide imaging</dc:subject>
          <dc:subject>sestamibi myocardial imaging</dc:subject>
          <dc:subject>SPECT MPI</dc:subject>
          <dc:subject>thallium (I) chloride</dc:subject>
          <dc:description>Background&lt;p&gt;Rest/stress [&lt;sup&gt;99m&lt;/sup&gt;Tc]technetium sestamibi single-photon emission computed tomography myocardial perfusion imaging (SPECT MPI) is a mainstay for evaluating coronary artery disease. However, fixed defects on standard MPI present a well-documented clinical challenge, as they can represent either non-viable scars or viable hibernating myocardium. We aimed to examine the incremental value and rate of diagnostic reclassification provided by performing subsequent dedicated cadmium-zinc-telluride (CZT) [&lt;sup&gt;201&lt;/sup&gt;Tl]thallium myocardial SPECT in patients presenting with fixed defects on standard sestamibi MPI.&lt;/p&gt;Methods&lt;p&gt;In this retrospective study, we analyzed 174 patients—totaling 2,958 myocardial segments—who underwent both protocols. Intermodality correlation was assessed, and the rates of segmental and patient-level reclassification (segments converting from &lt;50% maximum uptake on sestamibi to ≥50% maximum uptake on thallium) were quantified.&lt;/p&gt;Results&lt;p&gt;While a moderately high correlation was observed between the baseline uptake scores of the two modalities (Spearman's r = 0.817 for rest sestamibi vs. thallium), thallium imaging provided substantial additional information, with 48.0% of segments classified as fixed defects on sestamibi SPECT demonstrating improved uptake on thallium SPECT. At the patient level, 78.9% of individuals who had fixed defects on the initial sestamibi SPECT had at least one segment reclassified. Receiver operating characteristic analysis showed that a rest sestamibi uptake score of &lt;20% predicted a lack of reclassification with 99% specificity, although with low sensitivity (12%).&lt;/p&gt;Conclusion&lt;p&gt;In a selected cohort of patients presenting with fixed defects on standard rest/stress sestamibi SPECT MPI, supplementary imaging with thallium myocardial CZT SPECT provided incremental data, altering the clinical interpretation in nearly 80% of patients. However, in the absence of an independent viability reference standard, this finding represents intertracer diagnostic reclassification rather than proven functional recovery. A rest sestamibi uptake of &lt;20% demonstrated high specificity for non-reclassification; however, this cutoff should be interpreted cautiously as a potential gatekeeping finding when considering downstream testing rather than a rigid rule for omitting further myocardial viability evaluation.&lt;/p&gt;</dc:description>
          <dc:date>2026-10-02T04:40:10Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.3389/fcvm.2026.1901315.s001</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/Data_Sheet_1_Incremental_value_of_dedicated_201Tl_cadmium-zinc-telluride_thallium_SPECT_over_rest_stress_99mTc_technetium_sestamibi_SPECT_MPI_a_comparative_analysis_of_fixed_perfusion_defects_docx/34053837</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
